Charles River Laboratories International, Inc.
CRL · NYSE
12/31/2024 | 12/28/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | – | $25 | $480 | $493 |
| Dep. & Amort. | – | $362 | $314 | $304 |
| Deferred Tax | – | -$67 | -$51 | -$36 |
| Stock-Based Comp. | – | $70 | $72 | $74 |
| Change in WC | – | -$30 | -$102 | -$153 |
| Other Non-Cash | – | $375 | -$29 | -$62 |
| Operating Cash Flow | – | $735 | $684 | $620 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | – | -$233 | -$319 | -$325 |
| Net Acquisitions | – | -$5 | -$195 | -$120 |
| Inv. Purchases | – | -$53 | -$54 | -$158 |
| Inv. Sales/Matur. | – | $42 | $7 | $5 |
| Other Inv. Act. | – | $5 | -$2 | -$9 |
| Investing Cash Flow | – | -$245 | -$563 | -$608 |
| Financing Activities | – | – | – | – |
| Debt Repay. | – | -$412 | -$75 | $20 |
| Stock Issued | – | $0 | $0 | $0 |
| Stock Repurch. | – | -$119 | -$24 | -$39 |
| Dividends Paid | – | $0 | $0 | $0 |
| Other Fin. Act. | – | -$20 | $14 | -$24 |
| Financing Cash Flow | – | -$551 | -$86 | -$42 |
| Forex Effect | – | -$17 | $8 | $26 |
| Net Chg. in Cash | – | -$79 | $43 | -$5 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | – | $284 | $241 | $246 |
| End Cash | – | $206 | $284 | $241 |
| Free Cash Flow | – | $502 | $365 | $295 |